Wang Cai-Fu, Wang Ying-Shuo, Sun Yue-Feng
Departments of Pulmonology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Department of Otorhinolaryngology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Pediatr Int. 2016 May;58(5):385-388. doi: 10.1111/ped.12813. Epub 2015 Dec 29.
Infantile subglottic hemangioma (SH) can cause biphasic stridor, respiratory distress and even life-threatening airway compromise. Treatment of SH in infants has traditionally been characterized as a challenging situation with multiple therapeutic options without consensus as to which one is the best and with risks of severe side-effects. Four infants with SH were treated with propranolol. Treatment with oral propranolol resulted in resolution of symptoms within 2 days, followed by complete recovery. Propranolol appears to be an effective treatment for SH and should be used as a first-line treatment for SH when intervention is required.
小儿声门下血管瘤(SH)可导致双相性喘鸣、呼吸窘迫,甚至危及生命的气道梗阻。传统上,婴儿SH的治疗一直被认为是具有挑战性的情况,有多种治疗选择,但对于哪种是最佳选择尚无共识,且存在严重副作用的风险。4例SH婴儿接受了普萘洛尔治疗。口服普萘洛尔治疗在2天内使症状缓解,随后完全康复。普萘洛尔似乎是治疗SH的有效方法,在需要干预时应作为SH的一线治疗药物。